Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014;7 Spec No. 2(Spec Iss 2):15-7.

Biological therapies in moderate and severe psoriasis: perspectives and certainties

M M Constantin  1 , E Poenaru  1 , T Constantin  1 , C Poenaru  2 , V L Purcarea  1 , B R Mateescu  1
Affiliations
Review

Biological therapies in moderate and severe psoriasis: perspectives and certainties

M M Constantin et al. J Med Life. 2014.

Abstract

An inflammatory, proliferative condition with chronic evolution and systemic response, psoriasis, is positioned today among the most common inflammatory skin diseases affecting the Caucasian population worldwide. With a significant incidence, psoriasis has been increasingly defined as a disease with a major impact on the patient's life and the society to which he/she belongs. This paper conducts an analysis of the currently available therapies for the treatment of moderate and severe psoriasis, therapies with biological agents obtained through sophisticated genetic engineering technologies. Recent research and the increasing interest in therapeutic methods as complete and efficient as possible make us optimistic and confident in the future.

Keywords: anti-TNF; immunogenicity; psoriasis.

PubMed Disclaimer

References

    1. Christophers E. Psoriasis – epidemiology and clinical spectrum. Clin Exp. Dermatol. 2001;26:314–320. - PubMed
    1. Cargill M, Schrodi SJ, Chang M. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007;80:273–290. - PMC - PubMed
    1. Huerta C, Rivero E, Rodriguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol. 2007;143(12):1559–1565. - PubMed
    1. Mehta NN, Yu Y, Pinnelas R. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011;124:775 e771–775 e776. - PMC - PubMed
    1. Schafer I, Hacker J, Rustenbach SJ, Radtke M, Franzke N, Augustin M. Concordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatment. Eur J Dermatol. 2010;20:62–67. - PubMed

LinkOut - more resources